Serbia - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, Serbia Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale increased 9.5% year on year. At €8,980,270 in 2019, the country was number 13 among other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Serbia is overtaken by Portugal, which was ranked number 12 with €11,560,430.66 and is followed by Romania with €5,528,322. Denmark topped the ranking with €3,801,340,964.3 in 2019, that is a fall of 2.9% compared to 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Italy recorded the best 5 years average growth at +51.7% per year, while Netherlands was the worst growing country at -13.4% per year.

Loading...

Date Euros
2019 8,980,270.00
2018 8,349,541.00
2017 8,261,570.00
2016 7,840,344.00
2015 5,299,285.00
Download all data from 2011 to 2019

How does Serbia rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 16 Countries Euros Last YoY 5‑years CAGR
1 #1
Denmark
3,801,340,964.30 2019 -2.9 % +26.5 % View data
2 #2
Belgium
1,624,727,500.00 2018 +46.2 % NA View data
12 #12
Portugal
11,560,430.66 2019 +8.3 % +15.4 % View data
13 #13
Serbia
8,980,270.00 2019 +7.5 % +9.5 % View data
14 #14
Romania
5,528,322.00 2018 -3.0 % NA View data
Compare all 16 countries

Go Top